XenaCare Holdings, Incorporation - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for XenaCare Holdings, Incorporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

XenaCare Holdings, Incorporation. The Group's principal activity is to market and distribute clinical, life style performance and nutrition supplement products (NSPs). Its clinical NSP products include formulation and brand building of a line of NSPs for the replenishment of nutrients lost due to pharmaceutical medications, Lifestyles performance NSP products include formulation of a line of NSPs for the energy/lifestyle performance market to be sold through mass media buys, web sales and other channels of distribution and Protective NSP product in directed to the energy/lifestyle performance market. The Group's initial product, Sun Pill, is formulated to protect the skin when exposed to damaging ultraviolet rays. It operates in the United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report